Patch testing with neomycin sulfate

Contact Dermatitis

Volumn 43, Issue 5, 2000, Pages 295-302

  Bjarnason, Bolli ^a   Flosadóttir, Ellen ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allergic contact dermatitis; Application time; Bioengineering methods; Dose; Laser Dopper perfusion imaging; Laser Doppler perfusion scanning; Medicaments; Patch testing technique; Tape; Visual assessment

Indexed keywords

NEOMYCIN; PETROLATUM; POLYESTER; WATER;

ARTICLE; CLINICAL ARTICLE; CONTACT DERMATITIS; DIAGNOSTIC TEST; DOSE RESPONSE; DRUG EFFECT; DRUG FORMULATION; HUMAN; PATCH TEST; SKIN ALLERGY;

DERMATITIS, ALLERGIC CONTACT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; NEOMYCIN; PATCH TESTS; PETROLATUM; SENSITIVITY AND SPECIFICITY; VEHICLES; VISION;

EID: 0033833812     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2000.043005295.x     Document Type: Article

References (50)

1. Contact dermatitis from neomycin and framycetin
2. The identification of contact allergens by human assay (III). The maximization test: A procedure for screening and rating contact sensitizers
3. Mast cell depleting properties of neomycin
4. Neomycin sensitivity in the normal (nonatopic) individual
5. Contact dermatitis to neomycin sulfate
6. Allergic contact hypersensitivity to nickel, neomycin, ethylenediamine, and benzocaine
7. Allergic contact dermatitis in early infancy
8. Anaphylaktische Reaktionen beim Epicutantest
9. Oral provocation in eczematous contact allergy to neomycin and hydroxy-quinolines
10. Sensitivity to amikacin
11. Cross-sensitivity and aminoglycoside antibiotics
12. On cross-sensitization between neomycin, bacitracin, kanamycin and framycetin
13. Twelve years of sensitization to neomycin in Finland
14. Incidence of neomycin and framycetin sensitivity
15. The pattern of cross-sensitivity to neomycin
16. Tobramycin-neomycin cross-sensitivity
17. On allergic contact dermatitis to virginiamycin
18. Fixed drug eruption
19. Results of routine patch testing of 542 patients in Saskatoon, Canada
20. Patch testing in children: A study of 562 schoolchildren
21. Vergleichsuntersuchungen verschiedener Testmethoden bei der allergischen Kontaktsensibilisierung gegen Neomycinsulfat
22. Effect of test techniques on perfusion of neomycin sulfate patch tests. A comparative study with visual assessments
23. Objective non-invasive assessment of patch tests with laser Doppler perfusion scanning technique
24. Objective assessment of nickel sulfate patch test reactions with laser Doppler perfusion imaging
25. Visual and laser Doppler perfusion scanning assessments of Kathon® CG patch test reactions
26. Assessment of budesonide patch tests
27. Reactivity at edges of corticosteroid patch tests may be an indicator of a strong positive test response
28. Sensitizing and irritant properties of 3 environmental classes of diesel oil and their indicator dyes
29. Influence of patch-test application tape on reactions to sodium dodecyl sulphate
30. Effect of dark test-substance pigmentation on skin perfusion assessments and effect of test technique on balsam of Peru patch-test results
31. Easier patch testing with TRUE Test
32. Day 7 (D7) patch test reading - Valuable or not?
33. Delayed patch test reactions at days 7 and 9
34. Contact dermatitis to neomycin with false negative patch tests: Allergy established by intradermal and usage tests
35. Patch tests with neomycin
36. The interaction of surfactants with antimicrobial agents
37. Patch test reactions
38. Suitable bases for patch testing in tropical countries
39. Differences in the sensitizing capacity of neomycin in creams and in ointments
40. Neomycin sensitivity in atopic dermatitis and other eczematous conditions
41. Allergic hypersensitivity to neomycin
42. Neomycin: A review with particular reference to dermatological usage
43. Contact hypersensitivity to topical antibacterial agents
44. L'allergie a la neomycine
45. Detection of neomycin sensitivity
46. Contact dermatitis to neomycin with false negative patch tests: Allergy established by intradermal and usage tests
47. Contact dermatitis from neomycin due to dermal delayed (tuberculin-type) sensitivity
48. Testing neomycin contact sensitivity
49. Testing neomycin contact sensitivity
50. Dermal contact dermatitis from neomycin. Observation on forty cases